Literature DB >> 9679987

Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth.

P Fishman1, S Bar-Yehuda, L Vagman.   

Abstract

In this study, we investigated the basis of the resistance of muscles to tumor metastases. We found that a low molecular weight fraction (Mr <3000) of skeletal muscle cell-conditioned medium (MCM) markedly inhibits the proliferation of carcinoma, sarcoma, or melanoma cell lines in vitro. The MCM exerts a cytostatic effect on tumor cell growth and arrests the cells in G0/G1 of the cell cycle. However, normal cell proliferation of cells such as bone marrow cells or fibroblasts was found to be refractory to the influence of the MCM. A reduction in melanoma growth was observed in mice treated with the MCM. Adenosine was identified as one of the active components in the MCM by using high-performance liquid chromatography separations, mass spectra, and nuclear magnetic resonance analyses. At a concentration of 4 microM, equal to that found in the MCM, adenosine inhibits the proliferation of tumor cell lines (Nb2 lymphoma, K-562 leukemia, and LNCaP prostate carcinoma cells) while stimulating the proliferation of normal murine bone marrow cells. By similar methods, additional inhibitory components were detected in the MCM in a molecular mass range of 600-800 Da. The ability of adenosine and other low molecular weight components to specifically inhibit tumor cell growth in vitro and in vivo may account for the resistance of muscle to tumor metastases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679987

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  P2Y(AC)(-)-receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinase.

Authors:  P Claes; B Grobben; K Van Kolen; D Roymans; H Slegers
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

2.  Skeletal muscle metastasis from uterine leiomyosarcoma.

Authors:  J M O'Brien; D D Brennan; D H Taylor; D P Holloway; B Hurson; J C O'Keane; S J Eustace
Journal:  Skeletal Radiol       Date:  2004-05-04       Impact factor: 2.199

3.  Sarcopenia is associated with an increased risk of advanced colorectal neoplasia.

Authors:  Youn Su Park; Ji Won Kim; Byeong Gwan Kim; Kook Lae Lee; Jae Kyung Lee; Joo Sung Kim; Seong-Joon Koh
Journal:  Int J Colorectal Dis       Date:  2016-12-24       Impact factor: 2.571

4.  Involvement of ecto-5'-nucleotidase/CD73 in U138MG glioma cell adhesion.

Authors:  Angélica Regina Cappellari; Gabriela Jouglard Vasques; Luci Bavaresco; Elizandra Braganhol; Ana Maria Oliveira Battastini
Journal:  Mol Cell Biochem       Date:  2011-08-21       Impact factor: 3.396

5.  In vitro and in vivo studies on the inhibitory effects of myocardial cell culture medium on growth of a human lung adenocarcinoma cell line, A549.

Authors:  Y Zheng; J Zhou; S Z Fu; J Fan; J B Wu
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

6.  Resistance of muscle to tumor metastases: a role for a3 adenosine receptor agonists.

Authors:  S Bar-Yehuda; F Barer; L Volfsson; P Fishman
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

Review 7.  A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.

Authors:  Kenneth A Jacobson; Stefania Merighi; Katia Varani; Pier Andrea Borea; Stefania Baraldi; Mojgan Aghazadeh Tabrizi; Romeo Romagnoli; Pier Giovanni Baraldi; Antonella Ciancetta; Dilip K Tosh; Zhan-Guo Gao; Stefania Gessi
Journal:  Med Res Rev       Date:  2017-07-06       Impact factor: 12.944

8.  Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice.

Authors:  S Bar-Yehuda; T Farbstein; F Barer; G Ohana; P Fishman
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

9.  Skeletal muscle phenotypically converts and selectively inhibits metastatic cells in mice.

Authors:  Ara Parlakian; Iman Gomaa; Sounkary Solly; Ludovic Arandel; Alka Mahale; Gustav Born; Giovanna Marazzi; David Sassoon
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

10.  Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ratio in pathological stage IIIA (N2-positive) non-small cell lung cancer patients.

Authors:  Takuma Tsukioka; Nobuhiro Izumi; Shinjiro Mizuguchi; Chung Kyukwang; Hiroaki Komatsu; Michihito Toda; Kantaro Hara; Hikaru Miyamoto; Noritoshi Nishiyama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.